These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6112649)

  • 21. Effect of carbaryl on catecholamines in brain regions.
    Ray SK; Haque SJ; Poddar MK
    Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamine alterations in experimental hydrocephalus.
    Miyake H; Eghwrudjakpor PO; Sakamoto T; Mori K
    Childs Nerv Syst; 1992 Aug; 8(5):243-6. PubMed ID: 1394262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine-angiotensin II receptor interaction in primary cultures of rat brain.
    Sumners C; Raizada MK
    Am J Physiol; 1984 May; 246(5 Pt 1):C502-9. PubMed ID: 6144276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 3-OM-dopa on monoamine metabolism in rat brain.
    Gervas JJ; Muradás V; Bazán E; Aguado EG; de Yébenes JG
    Neurology; 1983 Mar; 33(3):278-82. PubMed ID: 6681870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of changing central and peripheral catecholamine levels in cysteamine-induced duodenal ulcer in the rat.
    Horner HC; Szabo S
    Life Sci; 1981 Dec; 29(23):2437-43. PubMed ID: 7321769
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine.
    Vathy I; Rimanoczy A; Eaton RC; Katay L
    Brain Res; 1994 Oct; 662(1-2):209-15. PubMed ID: 7859073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1990; 42(2):143-50. PubMed ID: 1980361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain catecholamine content and turnover in aging rats.
    Carfagna N; Trunzo F; Moretti A
    Exp Gerontol; 1985; 20(5):265-9. PubMed ID: 4092759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y alters monoamine turnover in the rat brain.
    Vallejo M; Carter DA; Biswas S; Lightman SL
    Neurosci Lett; 1987 Jan; 73(2):155-60. PubMed ID: 3822247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acute or chronic pentobarbital administration on the steady state levels and the turnover rates of catecholamines in discrete brain areas of mice.
    Nabeshima T; Fujimori K; Ho IK
    Prog Neuropsychopharmacol; 1981; 5(2):121-8. PubMed ID: 7267838
    [No Abstract]   [Full Text] [Related]  

  • 32. Avoidance facilitation by chlordiazepoxide-amphetamine combinations in mice: effect of alpha-methyl-p-tyrosine.
    Sansone M; Renzi P
    Psychopharmacology (Berl); 1981; 75(1):22-4. PubMed ID: 6117920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain ascorbic acid and block of the catecholamine synthesis induced by alpha-methyl-tyrosine.
    Loscalzo B; Agrusta A; Agrusta M; Crisci A; Genovese L; Marino M
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1735-8. PubMed ID: 6151844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines.
    Gasull T; Giralt M; Garcia A; Hidalgo J
    Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NE turnover in genetically hypertensive rats of Lyon strain. I. Brain nuclei.
    Sautel M; Sacquet J; Vincent M; Sassard J
    Am J Physiol; 1988 Oct; 255(4 Pt 2):H729-35. PubMed ID: 2902804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
    Mignot E; Laude D
    J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 40. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.